Chernett Jorey 4

What Happened Jorey Chernett, reported as a 10% owner of Oncology Institute, Inc. (TOI), made three open-market purchases (Code P) totaling 398,985 shares between March 13 and March 17, 2026. Transactions reported: 263,000 shares on 2026-03-13 at a weighted avg price of $2.92 ($767,960); 60,985 shares on 2026-03-16 at $3.29 ($200,641); and 75,000 shares on 2026-03-17 at $3.42 ($256,500). Combined value of the reported buys is about $1,225,101. These are outright purchases (buys), not sales or option exercises.

Key Details

• Dates & reported prices:
  • 2026-03-13: 263,000 shares @ $2.92 — $767,960 (Footnote F1: purchases in multiple fills at $2.77–$3.34; $2.92 is weighted avg).
  • 2026-03-16: 60,985 shares @ $3.29 — $200,641 (F2: fills ranged $3.25–$3.43).
  • 2026-03-17: 75,000 shares @ $3.42 — $256,500 (F3: fills ranged $3.39–$3.49).
• Total purchased: 398,985 shares for ~ $1.23M.
• Shares owned after the transactions: not specified in the provided data; filing identifies Chernett as a 10% beneficial owner.
• Footnotes: Prices shown are weighted averages; the filer offers to provide the breakdown of shares bought at each separate price on request (per F1–F3).
• Filing/timeliness: Form 4 filed 2026-03-17 reporting transactions from 2026-03-13 to 2026-03-17. No late-filing flag was indicated in the provided information.

Context

• These were open-market purchases (Code P), meaning shares were bought on the market rather than received via award or option exercise.
• As a 10% beneficial owner, Chernett is a large shareholder rather than necessarily an executive; such buys indicate additional insider ownership but do not alone explain motivation. This summary is factual and does not speculate on intent.